The performance of model-based versus rule-based phase I clinical trials in oncology: A quantitative comparison of the performance of model-based versus rule-based phase I trials with molecularly targeted anticancer drugs over the last 2 years
van Brummelen, E. M. J., Huitema, A. D. R., van Werkhoven, E., Beijnen, J. H., Schellens, J. H. M.
Published in Journal of Pharmacokinetics and Pharmacodynamics (01.06.2016)
Published in Journal of Pharmacokinetics and Pharmacodynamics (01.06.2016)
Get full text
Journal Article
Book Review
Safety and antitumor activity of the anti-PD-1 antibody pembrolizumab in patients with recurrent carcinoma of the anal canal
Ott, P.A., Piha-Paul, S.A., Munster, P., Pishvaian, M.J., van Brummelen, E.M.J., Cohen, R.B., Gomez-Roca, C., Ejadi, S., Stein, M., Chan, E., Simonelli, M., Morosky, A., Saraf, S., Emancipator, K., Koshiji, M., Bennouna, J.
Published in Annals of oncology (01.05.2017)
Published in Annals of oncology (01.05.2017)
Get full text
Journal Article